Benlysta Solution
Product Images NDC 49401-088

Product Visual Gallery

This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Benlysta (NDC 49401-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Benlysta Spl Graphic 01)

FDA Label Image

Figure 2 (Benlysta Spl Graphic 02)

FDA Label Image

Figure 3. Proportion (%) Of Sri-4 Responders (+/- Standard Error) By Visita (Benlysta Spl Graphic 03)

FDA Label Image

Benlysta Prefilled Syringe Parts (Benlysta Spl Graphic 04)

This text is a list of words or phrases and it seems to refer to some inspection related to needles and a cap window. However, it lacks context and it is not possible to provide a more precise description with this information.*

FDA Label Image

Needle Guard (Benlysta Spl Graphic 05)

FDA Label Image

Benlysta Prefilled Syringe (Benlysta Spl Graphic 06)

FDA Label Image

Gauze Pad Or Cotton Ball (Benlysta Spl Graphic 07)

FDA Label Image

Supplies_sharps_container_pfs (Benlysta Spl Graphic 08)

FDA Label Image

Figure_a_pfs (Benlysta Spl Graphic 09)

FDA Label Image

Figure_b_pfs (Benlysta Spl Graphic 10)

FDA Label Image

Figure_c_pfs (Benlysta Spl Graphic 11)

FDA Label Image

Figure_d_pfs (Benlysta Spl Graphic 12)

FDA Label Image

Figure_e_pfs (Benlysta Spl Graphic 13)

FDA Label Image

Figure_f_pfs (Benlysta Spl Graphic 14)

FDA Label Image

Figure_g_pfs (Benlysta Spl Graphic 15)

FDA Label Image

Figure_h_pfs (Benlysta Spl Graphic 16)

FDA Label Image

Figure_i_pfs (Benlysta Spl Graphic 17)

FDA Label Image

Figure_j_pfs (Benlysta Spl Graphic 18)

FDA Label Image

Autoinjector_parts_open-view_ai (Benlysta Spl Graphic 19)

This appears to be a list of items related to an inspection, including a ring cap window, Coes (which may refer to a type of wrench), gold and grey items, a needle guard and stopper, and an expiration date. It's unclear what specific product or process this pertains to.*

FDA Label Image

Benlysta Autoinjector (Benlysta Spl Graphic 20)

FDA Label Image

Gauze Pad Or Cotton Ball (Benlysta Spl Graphic 21)

FDA Label Image

Supplies_sharps_container_ai (Benlysta Spl Graphic 22)

FDA Label Image

Figure_a_ai (Benlysta Spl Graphic 23)

FDA Label Image

Figure_b_ai (Benlysta Spl Graphic 24)

FDA Label Image

Figure_c_ai (Benlysta Spl Graphic 25)

FDA Label Image

Figure_d_ai (Benlysta Spl Graphic 26)

FDA Label Image

Figure_e_ai (Benlysta Spl Graphic 27)

FDA Label Image

Figure_f_ai (Benlysta Spl Graphic 28)

FDA Label Image

Figure_g_ai (Benlysta Spl Graphic 29)

FDA Label Image

Figure_h_ai (Benlysta Spl Graphic 30)

Not available.*

FDA Label Image

Figure_i_ai (Benlysta Spl Graphic 31)

FDA Label Image

Figure_j_ai (Benlysta Spl Graphic 32)

FDA Label Image

Figure_k_ai (Benlysta Spl Graphic 33)

FDA Label Image

Benlysta 120 mg Per Vial Carton (Benlysta Spl Graphic 34)

Benlysta (belimumab) is a medication available in single-dose vials for intravenous infusion after dilution with sterile water for injection, USP. It is to be further diluted before use with 0.9% Sodium Chloride Injection, USP, 0.45% Sodium Chloride Injection, USP, or Lactated Ringer’s Injection, USP. Federal law requires dispensing of Benlysta with the medication guide provided. RX only.*

FDA Label Image

Benlysta 400 mg Per Vial Carton (Benlysta Spl Graphic 35)

Benlysta (belimumab) is an injection for intravenous infusion after dilution. The concentration of Benlysta is 80 mg/mL after reconstitution with sterile water for injection, USP. A further dilution is required before use to 250 mL of either 0.9% Sodium Chloride Injection, USP or 0.45% Sodium Chloride Injection, USP or Lactated Ringer's Injection, USP. BENLYSTA must be dispensed only with the Medication Guide provided with the carton as required by Federal Law. This is a single-dose vial and any unused portion must be discarded.*

FDA Label Image

Benlysta 200 mg-ml 4 Count Carton (Benlysta Spl Graphic 36)

This is a description of a medication called Benlysta, which is an injection administered subcutaneously once a week. It comes in a package that includes four single-dose 1-mL profiled autoinjectors, as well as instructions for use, a medication guide, and prescribing information. Dispensing of Benlysta is required by law with the medication guide provided in the package. The package is labeled with NDC code 49401-088-35 and is only available with a prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.